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Results: Mean SF HA (±SD) was 2.24±0.60 mg/ml. There was no 
significant difference between KL grades II (2.31±0.60) and Itl 
(2.35±0.67); p=0.91. HA SF level was correlated with PGE2 
(r=0.58, p=0.O01), PLA2 (r=0.32, p=0.02), COMP (r=0.29, p=0.04) 
and active collagenase (r=0.31 1, p=0.02). HA was unrelated to 
YKL40 (r=0.25, p=0.07) and SF total proteins ( r=0.01, p=O.93). 
Other positive correlations between PLA2 and YKL40 (r=0.34, 
p=0.01), active cotlagenase and COMP (r=0.28, p=0.04) and PGE2 
(r=0+34, p=0.01) were found. 
Conclusion: These results show that SF HA is an inflammatory 
marker of CA joint which is highly correlated to other markers of 
both inflammatory process (PGE2 and PLA2) and cartilage 
metabolism (collagenase and COMP). 
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CORRELATION OF CD44, HSP70, AND HYALURONAN IN 
SYNOVIAL TISSUE WITH CLINICAL AND RADIOLOGICAL 
SCORES_ 
Fuchs S., Wildenau G., Lohmann C., Rolauffs B., Goetz W. 
Orthopaedic Department, University of Munster, Germany 
Aim: Correlation of clinical and radiological scores with synovial 
expression of CD44, HSP70, and hyaluronan in osteoarthritis. 
Material and Methods: Synovial tissue from the knee joint of 38 
patients with different grades of primary osteoarthritis (according 
to Kellgren) were collected, fixed in 10% buffered formalin (pH 
7.0), and embedded in paraffin. After decalcification speci- 
mens were cut in 3.5~.m sections and analyzed for CD44H, 
CD44v5, HSP70, and hyaluronan using monoclonal antibodies. 
Antigen detection was performed using the PAP method. 
Hematoxylin/eosin, alcian blue, and safranin 0 was used for 
histological staining. Analysis of specimens was carried out five 
times by two independent examiners. Histopathomorphological 
results were classified according to Pelletier. Immunhisto- 
chemical staining was graded into 0 = no, 1 = low, 2 = moderate, 
3 = intensive. For clinical examination Visual Analog Scale (VAS), 
Knee Society Score (KSS), and Lequesne Score were used. 
Results: Clinical examinations revealed 8.7 ± 1.2 (mean ± SD) 
points for VAS, 70.68 ± 41.45 (mean ± SD) points for KSS, and 
16.88 ± 6.74 (mean ± SD) points for the Lequesne Score. Analysis 
according to Pelletier achieved 6.9 ± 1.32 (mean ± SD) points. 
Immunhistochemical staining was 1.53 + 0.89 (mean ± SD) for 
CD44H 113 + 0.99 (mean ±SD) for CD44v5, 0.39 ± 0.59 (mean ± 
SD) for hyaluronan, and 1.08 ±1.15 (mean ± SD) for HSP70. No 
significant differences were found between the grades of 
osteoarthritis. Correlation analysis was significant (p <0.05) for 
age and Pelletier classification (0.323), KSS and Lequesne Score 
(0.329), HSP70 and age (0.375), CD44H and BMI (0.386), CD44v5 
and age (0.409), hyaluronan and VAS (0.345), CD44H and 
hyaluronan (0.362), and Lequesne Score and hyaluronan (0.329). 
A significance level of p <0.01 was only achieved for VAS and 
KSS. 
Conclusions: The results indicate that expression of HSP70 and 
CD44v5 is rather associated with age than with clinical par- 
ameters. In contrast, the correlation of hyaluronan with CD44H 
and clinical symptoms points to a role for hyaluronan and 
probably its receptor CD44H in osteoarthritis. 
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SERUM C-TELOPEPTIDE OF TYPE i COLLAGEN IN 
EROSIVE OSTEOARTHRITIS OF THE HANDS 
G. Rovetta, L. Buffrini, MC. Grignolo, A. Brignone, R Monteforte. 
DISEM, Rheumatological Center, University of Genova, Italy 
Aim: The aim of the study was to assess the serum levels of CTx 
in patients with erosive osteoarthritis of the hands, a disease with 
an elevated bone turnover. 
Patients and Methods: Samples for serum C-telopeptide of type 
I collagen (CTx), were obtained from 19 patients (18 women and 
1 man; age 49,79 years) with erosive osteoarthritis of the hands, 
and from 23 patients (22 women and 1 man; age 48-90 years) 
with osteoporosis. The mean duration of diseases was about 7 
years. Admission cdteda for EOA was the radiological evidence of 
central erosions in 2-6 interphalangeal joints. Osteoporotic 
patients had a z-score of -2.5 SD at the examination with DEXA 
Lunar-Expert densitometer. The serum Cross Laps One Step 
ELISA kit was employed. 
Results: The serum CTx concentration was 3376+/-1622 
pmol/litre (mean +/SD) in osteoporotic patients and 4720+/-1895 
pmol/litre in osteoarthritic patients. A significant difference was 
observed between the two groups (P<0.01). Osteoporotic 
patients 7/23 (30.4%) presented elevated CTx values versus 
osteoarthritic patients where abnormal CTx values were 12/19 
(63.1%); the difference was statistically significant (P<0.0 1). 
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Conclusions: Serum C-telopeptide of type I collagen (CTx) was 
found elevated in different conditions with high bone turnover 
expecially in osteoporotic patients. The study demonstrates than 
the patients affected by erosive osteoarthritis of the hands pre- 
sented serum levels of CTx more elevated than osteoporotic 
patients 
PB53 
BIOLOGICAL CHARACTERISTICS OF THE RAPIDLY 
DESTRUCTIVE OSTEOARTHRITIS OF THE HIP: 
A CASE-CONTROL STUDY 
Florence Merle-Vincent, Thierry Conrozier, Stephanie Richard, 
Pierre Mathieu, Michel Richard, Eric Vignon 
Department of Rhumatology, Centre hospitalier Lyon-sud, 
69495 Pierre-Bdnite cedex France 
Objective : To determine the biological characteristics of the 
rapidly destructive hip osteoarthdtis (RDHOA) in relation to 
common hip CA. 
Methods: Case-control study. Three groups: group I : 27 patients 
suffering from RDHOA (annual joint space narrowing JSN>2 mm 
per year); group I1:27 patients with slow progressive hip CA 
(annual JSN<O.50 rnm/year) matched by age and sex; group II1 : 
27 patients with slow progressive hip CA matched by the joint 
space thickness. The studied serum markers were: C Reactive 
Protein (CRP) using high sensitive nephelemetry, Cartilage 
Oligomeric Matrix Protein (COMP), hyaluronic acid (HA), tissue 
inhibitor of metalloproteinase type 1 (TIMP-1), Matrix metallo- 
proteinase type I (MMP-1), type I collagen C-terminal propeptide 
